Asymmetry Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-68,381
Closed -$421K 37
2017
Q1
$421K Buy
+68,381
New +$421K 0.59% 25